Skip to main content
. 2021 Jun 10;8:679934. doi: 10.3389/fcvm.2021.679934

Figure 2.

Figure 2

Flow diagram of study inclusion and follow-up. TG, thrombin generation; VKA, vitamin K antagonist; DOAC, direct-acting oral anticoagulants; LMWH, low molecular weight heparin; DAFT, dual antiplatelet therapy; PCI, percutaneous coronary intervention.